Science Explorer Back to mapMap
Discussion
Institution · Düsseldorf · Germany

Michalski Huettermann and Partner

mhpatent.de/html/1index_e.htmlROR OpenAlex
Research works
51
▲ 42% vs 2018-21
Citations
270
5.3 per fractional work
Top-10% rate
2.6%
all institutions 10.0%
Open access
30%
world 40%
International
10%
world 18%
Michalski Huettermann and Partner

Not ranked overall: Michalski Huettermann and Partner is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Michalski Huettermann and Partner work in?

In all years, 34% of research at Michalski Huettermann and Partner is in Health Sciences, 32% in Social Sciences. Its largest fields are Medicine (30%), Business, Management and Accounting (15%), Biochemistry, Genetics and Molecular Biology (14%). It does 1.4× the world's share of Social Sciences.

Health Sciences: 18 fractional works · 34.2% of its workMedicine: 15 fractional works · 30.1% of its workPublic Health, Environmental and Occupational Health: 6 fractional works · 11.7% of its workRadiology, Nuclear Medicine and Imaging: 3 fractional works · 6.6% of its workOncology: 3 fractional works · 4.9% of its workPhysiology: 2 fractional works · 2.9% of its workInfectious Diseases: 1 fractional works · 2.5% of its workReproductive Medicine: 0 fractional works · 1.0% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.3% of its workHealth Professions: 2 fractional works · 4.1% of its workGeneral Health Professions: 1 fractional works · 2.8% of its workPhysical Therapy, Sports Therapy and Rehabilitation: 1 fractional works · 1.3% of its workSocial Sciences: 16 fractional works · 32.0% of its workBusiness, Management and Accounting: 8 fractional works · 14.9% of its workManagement of Technology and Innovation: 3 fractional works · 6.2% of its workBusiness and International Management: 2 fractional works · 4.2% of its workStrategy and Management: 1 fractional works · 2.3% of its workAccounting: 1 fractional works · 1.9% of its workManagement Information Systems: 0 fractional works · 0.3% of its workSocial Sciences: 6 fractional works · 10.8% of its workLaw: 2 fractional works · 4.5% of its workSociology and Political Science: 2 fractional works · 4.4% of its workPolitical Science and International Relations: 1 fractional works · 1.3% of its workHealth: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEconomics, Econometrics and Finance: 2 fractional works · 3.8% of its workEconomics and Econometrics: 2 fractional works · 3.8% of its workPsychology: 1 fractional works · 1.9% of its workSocial Psychology: 1 fractional works · 1.9% of its workDecision Sciences: 0 fractional works · 0.6% of its workInformation Systems and Management: 0 fractional works · 0.6% of its workLife Sciences: 12 fractional works · 22.4% of its workBiochemistry, Genetics and Molecular Biology: 7 fractional works · 14.3% of its workMolecular Biology: 6 fractional works · 10.7% of its workGenetics: 1 fractional works · 1.6% of its workAging: 0 fractional works · 0.6% of its workBiochemistry: 0 fractional works · 0.6% of its workBiotechnology: 0 fractional works · 0.3% of its workCancer Research: 0 fractional works · 0.3% of its workImmunology and Microbiology: 3 fractional works · 6.1% of its workImmunology: 3 fractional works · 6.1% of its workNeuroscience: 1 fractional works · 1.1% of its workCognitive Neuroscience: 0 fractional works · 1.0% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 0 fractional works · 1.0% of its workPlant Science: 0 fractional works · 1.0% of its workPhysical Sciences: 6 fractional works · 11.3% of its workComputer Science: 2 fractional works · 4.5% of its workArtificial Intelligence: 2 fractional works · 3.2% of its workInformation Systems: 0 fractional works · 1.0% of its workSignal Processing: 0 fractional works · 0.3% of its workEngineering: 2 fractional works · 4.2% of its workBiomedical Engineering: 1 fractional works · 1.6% of its workElectrical and Electronic Engineering: 0 fractional works · 0.6% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.6% of its workMechanics of Materials: 0 fractional works · 0.6% of its workCivil and Structural Engineering: 0 fractional works · 0.3% of its workMechanical Engineering: 0 fractional works · 0.3% of its workMaterials Science: 1 fractional works · 1.3% of its workMaterials Chemistry: 0 fractional works · 1.0% of its workCeramics and Composites: 0 fractional works · 0.3% of its workEnvironmental Science: 0 fractional works · 0.6% of its workNature and Landscape Conservation: 0 fractional works · 0.6% of its workMathematics: 0 fractional works · 0.6% of its workModeling and Simulation: 0 fractional works · 0.6% of its workALL ITS WORKMichalskiHuettermann and…51fractional works, all years
Life Sciences22%Physical Sciences11%Health Sciences34%Social Sciences32%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 16 fields, with their numbers
    1. Medicine1530.1%
    2. Health Professions24.1%
    1. Business, Management and Accounting814.9%
    2. Social Sciences610.8%
    3. Economics, Econometrics and Finance23.8%
    4. Psychology11.9%
    5. Decision Sciences00.6%
    1. Biochemistry, Genetics and Molecular Biology714.3%
    2. Immunology and Microbiology36.1%
    3. Neuroscience11.1%
    4. Agricultural and Biological Sciences01.0%
    1. Computer Science24.5%
    2. Engineering24.2%
    3. Materials Science11.3%
    4. Environmental Science00.6%
    5. Mathematics00.6%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 6.36× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 4.07× its world share, 0 worksImmunology and Micro…Computer Science: 0.51× its world share, 0 worksComputer ScienceEngineering: 0.53× its world share, 1 worksEngineeringHealth Professions: 0.50× its world share, 0 worksHealth ProfessionsMedicine: 1.01× its world share, 2 worksMedicineBusiness, Management and Accounting: 7.42× its world share, 2 worksBusiness, Management…Decision Sciences: 4.13× its world share, 0 worksDecision SciencesSocial Sciences: 0.11× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Business, Management and Accounting, 7.4×. Every wedge is a field page.

All 9 fields, with their numbers
  1. Business, Management and Accounting7.42×2 works
  2. Biochemistry, Genetics and Molecular Biology6.36×3 works
  3. Decision Sciences4.13×0 works
  4. Immunology and Microbiology4.07×0 works
  5. Medicine1.01×2 works
  6. Engineering0.53×1 works
  7. Computer Science0.51×0 works
  8. Health Professions0.50×0 works
  9. Social Sciences0.11×0 works

Who are the top researchers at Michalski Huettermann and Partner?

Ranked on the quality score, Eckhard Klapp, Ulrich Storz and Grzegorz lead among researchers whose main affiliation is Michalski Huettermann and Partner.

  1. 1 Eckhard Klapp Germany · #2,733,934 worldwide 13 citations · 32 works
  2. 2 Ulrich Storz Germany · #3,449,946 worldwide 392 citations · 51 works
  3. 3 Grzegorz Germany · #4,973,909 worldwide 21 citations · 23 works
All ranked researchers at Michalski Huettermann and Partner

What are the most cited papers from Michalski Huettermann and Partner?

The most cited paper from Michalski Huettermann and Partner is "Intellectual property protection" (Ulrich Storz, 2011), with 118 citations. Next come "Pulmonary Artery Banding for Functional Regeneration of End-Stage Dilated Cardiomyopathy in Young Children" (63) and "Rituximab" (41).

Most cited papers
#PaperReleasedCitations
1 Intellectual property protection Ulrich Storz · mAbs Open access May 2011 118
2 Pulmonary Artery Banding for Functional Regeneration of End-Stage Dilated Cardiomyopathy in Young Children Dietmar Schranz et al. · Circulation Open access 26 Mar 2018 63
3 Rituximab Ulrich Storz · mAbs Open access 7 May 2014 41
4 Contact-free single-cell cultivation by negative dielectrophoresis Magnus Sebastian Jaeger, Katja Uhlig, Thomas Schnelle et al. · Journal of Physics D Applied Physics 8 Aug 2008 37
5 Antibody-drug conjugates: Intellectual property considerations Ulrich Storz · mAbs Open access 20 Aug 2015 17
All 60 most cited papers, with filters and sorting

Which keywords describe research at Michalski Huettermann and Partner?

By fractional works in all years, weighted toward what it does more of than the world: Monoclonal Antibodies, Innovation, Emerging Markets, Entrepreneurship, Medical Ethics, Patient Rights, Genome Engineering and RNA-Guided.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Innovation6▲ 13×4 topics
  2. Monoclonal Antibodies6▲ 83×3 topics
  3. Emerging Markets4▲ 169×2 topics
  4. Entrepreneurship4▲ 31×2 topics
  5. Medical Ethics4▲ 40×1 topic
  6. Patient Rights4▲ 72×1 topic
  7. Genome Engineering4▲ 117×1 topic
  8. RNA-Guided4▲ 117×1 topic
  9. Biopharmaceuticals3▲ 93×2 topics
  10. Immunogenicity3▲ 124×2 topics
  11. Glycosylation3▲ 28×2 topics
  12. Intellectual Property Rights3▲ 133×1 topic
  13. Patent Analysis3▲ 361×1 topic
  14. Bioanalytical Methods3▲ 403×1 topic
  15. Biosimilars3▲ 403×1 topic
  16. Therapeutic Antibodies3▲ 46×2 topics
  17. Antibody Engineering3▲ 55×1 topic
  18. Ethical Issues3▲ 57×4 topics
  19. Fc Receptors3▲ 55×1 topic
  20. Bottom of the Pyramid2▲ 140×1 topic
  21. Frugal Innovation2▲ 140×1 topic
  22. Public Health2▲ 3.1×4 topics
  23. Global Collaboration2▲ 100×1 topic
  24. Health Biotechnology2▲ 216×1 topic
  25. Regulatory Challenges2▲ 49×2 topics
  26. Clinical Trials2▲ 5.2×2 topics
  27. CAR T Cells2▲ 68×1 topic
  28. Chimeric Antigen Receptor2▲ 68×1 topic
  29. Human Rights2▲ 3.4×2 topics
  30. Patient Safety2▲ 24×1 topic
  31. Stem Cell Regulation2▲ 127×1 topic
  32. Chronic Diseases1▲ 9.3×2 topics
  33. Corporate Governance1▲ 4.8×4 topics
  34. Governance1▲ 8.7×2 topics
  35. Vaccine1▲ 6.2×2 topics
  36. Data Protection1▲ 125×2 topics
  37. Legal Methodology1▲ 80×1 topic
  38. Party Competition1▲ 147×1 topic
  39. Bildungsungleichheit1▲ 69×1 topic
  40. Coaching1▲ 102×1 topic

Which research topics does Michalski Huettermann and Partner publish most on?

By volume in 2022-now: CRISPR and Genetic Engineering, Innovation and Socioeconomic Development, SARS-CoV-2 and COVID-19 Research and Monoclonal and Polyclonal Antibodies Research.

CRISPR and Genetic Engin…2CRISPR and Genetic Engineering: 2 fractional worksInnovation and Socioecon…2Innovation and Socioeconomic Development: 2 fractional worksSARS-CoV-2 and COVID-19 …1SARS-CoV-2 and COVID-19 Research: 1 fractional worksMonoclonal and Polyclona…0Monoclonal and Polyclonal Antibodies Research: 0 fractional worksCOVID-19 Digital Contact…0COVID-19 Digital Contact Tracing: 0 fractional worksBiosimilars and Bioanalytical Methods: 0 fractional worksGenetics, Aging, and Longevity in Model Organisms: 0 fractional worksRNA Interference and Gene Delivery: 0 fractional worksAcademic Publishing and Open Access: 0 fractional worksHER2/EGFR in Cancer Research: 0 fractional works
Molecular BiologyBusiness and International ManagementInfectious DiseasesRadiology, Nuclear Medicine and Imaging5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CRISPR and Genetic Engineering Molecular Biology 2 works
  2. 2 Innovation and Socioeconomic Development Business and International Management 2 works
  3. 3 SARS-CoV-2 and COVID-19 Research Infectious Diseases 1 works
  4. 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  5. 5 COVID-19 Digital Contact Tracing Information Systems 0 works
  6. 6 Biosimilars and Bioanalytical Methods Immunology 0 works
  7. 7 Genetics, Aging, and Longevity in Model Organisms Aging 0 works
  8. 8 RNA Interference and Gene Delivery Molecular Biology 0 works
  9. 9 Academic Publishing and Open Access Information Systems and Management 0 works
  10. 10 HER2/EGFR in Cancer Research Oncology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available29.6%not open70.4%

World: 40% of research is openly available.

with international co-authors9.7%domestic only90.3%

World: 18% is written across borders.

How has Michalski Huettermann and Partner's research output changed?

Output in 2022-2025 was 42% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Michalski Huettermann and Partner as a percentage of every work published that year, 0.000027% in 2024.

still counting0.00025%0.00050%0.00075%Michalski Huettermann and Partner0.000043% in 2025200020102020

Fractional works of Michalski Huettermann and Partner over all fractional works that year. How the balance of science has shifted.

Other research institutions in Düsseldorf

All research institutions in Düsseldorf

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Michalski Huettermann and Partner. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.